Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Brain Single Photon Emission Computed Tomography and Quantitative Electroencephalography In Former NFL Players: A Single-Site Exploratory Pilot Study
1 other identifier
interventional
100
1 country
1
Brief Summary
The investigators primary objective is to acquire preliminary data on one-hundred former NFL veterans with at least one full year of professional service using brain SPECT imaging in order to assess the degree to which NFL football puts players at risk for traumatic brain injury (TBI). TBI severity shall be gauged via visual inspection by a clinician trained in neuroanatomy, and also by a statistical comparison of subjects' brains to an in-house proprietary database comprised of the brains of healthy subjects. The investigators secondary objective is to acquire additional data on these players such that investigators may establish causative factors and risks associated with said TBI. The investigators tertiary objective is to acquire data on subjects using various mental health metrics in order to determine the effects of TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 1, 2010
CompletedFirst Posted
Study publicly available on registry
January 24, 2012
CompletedJanuary 24, 2012
January 1, 2012
1.1 years
October 1, 2010
January 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A concentration SPECT scan will be given to assess the changes in regional cerebral blood flow to the brain in our study participants.
For the concentration study the subject will start the Conner's Continuous Performance Task, a 15-minute computer-administered test of attention, subsequent to the accommodation period. Three minutes into task performance 20 milliCuries of Tc-99m-hexamethylpropylene amine oxime will be injected through the catheter with attention to minimal disruption of the subject's attention task. The subject will proceed to completion of the attention task. The concentration scans will then be compared to a healthy brain subject normative database.
The SPECT scan is one day imaging exam. A follow up scan will be performed following a 2-12 month supplement intervention.
Secondary Outcomes (1)
Quantitative electroencephalography (QEEG) will be used to assess the damage to neural networks in our study participants.
The QEEG testing is one day exam. A follow up test will be performed following a 2-12 month supplement intervention.
Study Arms (1)
Supplement intervention
EXPERIMENTALDietary Supplement: Multivitamin, Omega 3 Supplement, Brain and Memory Formula
Interventions
We recommend the following protocol: 1. 2 tablets of a high quality multivitamin BID 2. 2 capsules of omega 3 fish oil BID for a total of 3 grams daily 3. 3 capsules of a brain and memory formula BID which contains Acetyl-L-Carnitine (HCL) 1000 mg, Ginkgo Biloba Extract 120 mg, Alpha-Lipoic Acid (ALA) 300 mg, Huperzine A (Huperzia serrata)150 mcg, N-Acetyl-L-Cysteine (NAC) 600mg, Phosphatidyl Serine (soy) 100 mg, Vinpocetine 15mg 4. Weight loss
Eligibility Criteria
You may qualify if:
- Subjects must be at least 18 years of age
- Each subject must have been on an active NFL roster for a minimum of one year
You may not qualify if:
- Any subjects who could not cease taking psychoactive medications (recreational or otherwise) for an appropriate washout period prior to scanning were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amen Clinics, Inc.
Newport Beach, California, 92660, United States
Related Publications (2)
Amen DG, Newberg A, Thatcher R, Jin Y, Wu J, Keator D, Willeumier K. Impact of playing American professional football on long-term brain function. J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):98-106. doi: 10.1176/jnp.23.1.jnp98.
PMID: 21304145RESULTAmen DG, Wu JC, Taylor D, Willeumier K. Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs. 2011 Jan-Mar;43(1):1-5. doi: 10.1080/02791072.2011.566489.
PMID: 21615001RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel G Amen, MD
Amen Clinics, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2010
First Posted
January 24, 2012
Study Start
May 1, 2009
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
January 24, 2012
Record last verified: 2012-01